Top compounds associated with response to LRRC46


Feature Type Standardized
Nominal ANOVA
mRNA foretinib CTRPv2 pan-cancer AAC -0.029 0.4
mRNA XL-184 GDSC1000 pan-cancer AAC 0.027 0.4
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.023 0.4
mRNA HG-5-88-01 GDSC1000 pan-cancer AAC -0.037 0.4
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.029 0.4
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.043 0.4
mRNA salermide CTRPv2 pan-cancer AAC 0.036 0.4
mRNA canertinib CTRPv2 pan-cancer AAC 0.029 0.4
mRNA VU0155056 CTRPv2 pan-cancer AAC 0.029 0.4
Download CSV